Quarterly Transactions Made in Immunovant, Inc. (IMVT)
This table provides information about the institutional ownership of Immunovant, Inc. (IMVT). The information is specifically focused on institutions that hold shares of Immunovant, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 4,212,875 | 4,223,544 | 8,436,419 | 6,024,503 | 4,911,020 | 10,935,523 | -2,499,104 | |
Q4 2021 | 2,320,538 | 6,623,751 | 8,944,289 | 4,025,254 | 795,946 | 4,821,200 | 4,123,089 | |
Q1 2022 | 7,735,155 | 832,690 | 8,567,845 | 4,451,559 | 2,499,373 | 6,950,932 | 1,616,913 | |
Q2 2022 | 4,389,913 | 350,351 | 4,740,264 | 2,491,854 | 1,768,520 | 4,260,374 | 479,890 | |
Q3 2022 | 2,408,769 | 8,693,555 | 11,102,324 | 4,287,638 | 0 | 4,287,638 | 6,814,686 | |
Q4 2022 | 10,660,651 | 13,253,720 | 23,914,371 | 8,120,336 | 0 | 8,120,336 | 15,794,035 | |
Q1 2023 | 8,890,374 | 3,461,817 | 12,352,191 | 7,523,496 | 435,751 | 7,959,247 | 4,392,944 | |
Q2 2023 | 7,631,169 | 4,007,717 | 11,638,886 | 8,409,659 | 29,466 | 8,439,125 | 3,199,761 | |
Q3 2023 | 11,364,607 | 10,778,246 | 22,142,853 | 8,400,518 | 219,901 | 8,620,419 | 13,522,434 | |
Q4 2023 | 6,232,760 | 11,201,492 | 17,434,252 | 10,299,420 | 0 | 10,299,420 | 7,134,832 | |
Q1 2024 | 9,075,885 | 4,054,434 | 13,130,319 | 7,144,555 | 0 | 7,144,555 | 5,985,764 | |
Q2 2024 | 12,881,362 | 2,830,037 | 15,711,399 | 6,987,712 | 0 | 6,987,712 | 8,723,687 | |
Q3 2024 | 10,481,651 | 1,753,494 | 12,235,145 | 4,085,322 | 0 | 4,085,322 | 8,149,823 |